Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases
- PMID: 9371029
Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases
Abstract
Objective: To improve Skindex, a dermatologic quality-of-life instrument.
Design: Cross-sectional and longitudinal questionnaire study.
Setting: Dermatology clinic of a Veterans Affairs hospital and private dermatology practices.
Patients: Patients waiting for dermatology appointments; 201 patients responded to the original version of Skindex and 692 additional patients to the revised version.
Main outcome measures: Reproducibility, internal consistency reliability, and validity of the revised version of Skindex. The revised version was compared with the original in 3 ways: the amount of time patients need to complete it; discriminative capability, determined as the number of items to which patients chose the same response; and evaluative capability, determined as the number of scales that were responsive to patients' reports of clinical change.
Results: With the revised 29-item version of Skindex, scale scores were reproducible after 72 hours (r = 0.88-0.92) and were internally reliable (Cronbach alpha = 0.87-0.96). The instrument demonstrated both construct and content validity; patients with psoriasis and eczema responded with higher scores than those with isolated lesions; in an exploratory principal axes factor analysis with an oblique rotation, 97% of the common variance was explained by 3 factors that correlated with the a priori scales; and most patients' responses to an open-ended question about their skin disease were addressed by items in the instrument. The average time to complete the revised instrument was 5 minutes (compared with 15 minutes for the original version). For only 3 items (10%) did 70% or more of patients choose the same response (vs 17 [28%] of items in the original version). All scales changed significantly in the expected direction in patients who reported that their skin had changed after 3 months (vs only 3 of 8 scales originally).
Conclusion: The 29-item version of Skindex remains reliable and valid, but has decreased respondent burden and improved discriminative and evaluative capability.
Similar articles
-
Arabic version of Skindex-16: translation and cultural adaptation, with assessment of reliability and validity.Int J Dermatol. 2007 Mar;46(3):247-52. doi: 10.1111/j.1365-4632.2007.03013.x. Int J Dermatol. 2007. PMID: 17343578
-
Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases.J Cutan Med Surg. 2001 Mar-Apr;5(2):105-10. doi: 10.1007/BF02737863. Epub 2001 Mar 21. J Cutan Med Surg. 2001. PMID: 11443481
-
Turkish version of Skindex-29.Int J Dermatol. 2007 Apr;46(4):350-5. doi: 10.1111/j.1365-4632.2007.03008.x. Int J Dermatol. 2007. PMID: 17442071
-
[Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].Encephale. 2003 Mar-Apr;29(2):137-47. Encephale. 2003. PMID: 14567165 Review. French.
-
Clinical meaning in skin-specific quality of life instruments: a comparison of the Dermatology Life Quality Index and Skindex banding systems.Dermatol Clin. 2012 Apr;30(2):333-42, x. doi: 10.1016/j.det.2011.11.010. Dermatol Clin. 2012. PMID: 22284147 Review.
Cited by
-
The efficacy of a health-related quality-of-life intervention during 48 weeks of biologic treatment of patients with moderate to severe psoriasis: study protocol for a multicenter randomized controlled trial.Trials. 2012 Dec 8;13:236. doi: 10.1186/1745-6215-13-236. Trials. 2012. PMID: 23216943 Free PMC article. Clinical Trial.
-
Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire.Health Qual Life Outcomes. 2012 May 24;10:56. doi: 10.1186/1477-7525-10-56. Health Qual Life Outcomes. 2012. PMID: 22624984 Free PMC article. Clinical Trial.
-
Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis.JAMA Dermatol. 2013 May;149(5):550-6. doi: 10.1001/jamadermatol.2013.60. JAMA Dermatol. 2013. PMID: 23677081 Free PMC article.
-
The Use of HSQoL-24 in an Assessment of Quality-of-Life Impairment among Hidradenitis Suppurativa Patients: First Look at Real-Life Data.J Clin Med. 2021 Nov 22;10(22):5446. doi: 10.3390/jcm10225446. J Clin Med. 2021. PMID: 34830727 Free PMC article.
-
Development of a working core outcome set for cutaneous lupus erythematosus: a practical approach to an urgent unmet need.Lupus Sci Med. 2021 Dec;8(1):e000529. doi: 10.1136/lupus-2021-000529. Lupus Sci Med. 2021. PMID: 34969875 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical